$CHTP News Wednesday’s movers: Herbalife slumps after

New Post Public Reply Private Reply Replies (0) Message Board

Jan 29, 2014 at 10:24 AM

$CHTP News

Wednesday’s movers: Herbalife slumps after call 4:57 p.m. Feb. 20, 2013 - Sue Chang
Chelsea Therapeutics CEO, other execs step down 6:17 a.m. July 10, 2012 - MarketWatch.com
Thursday’s biggest gaining and declining stocks 12:00 p.m. May 31, 2012 - MarketWatch
Chelsea shares tumble on FDA setback 9:53 a.m. March 29, 2012 - MarketWatch.com
FDA seeks more info from Chelsea Therapeutics 7:22 a.m. March 29, 2012 - Greg Morcroft
Chelsea Therapeutics falls 23% in premarket 7:04 a.m. March 29, 2012 - Steve Gelsi
FDA decision nears for Chelsea Therapeutics 11:10 a.m. March 14, 2012 - MarketWatch.com
Friday’s biggest gaining and declining stocks 4:40 p.m. Feb. 24, 2012 - Kate Gibson
Chelsea Therapeutics soars on FDA nod 1:13 p.m. Feb. 24, 2012 - Val Brickates Kennedy
Chelsea Therapeutics up 71% in premarket 7:58 a.m. Feb. 24, 2012 - Steve Gelsi
Stocks to watch Friday: Deckers, Salesforce, Crocs 6:49 a.m. Feb. 24, 2012 - MarketWatch
Monday’s biggest gaining and declining stocks 4:51 p.m. Feb. 13, 2012 - MarketWatch
Chelsea plunges 36% ahead of FDA update 10:54 a.m. Feb. 13, 2012 - Val Brickates Kennedy
Chelsea Therapeutics jumps 8% on ADHD study 11:15 a.m. July 26, 2011 - Val Brickates Kennedy
Biogen, Acura lead drug stocks north 2:54 p.m. June 20, 2011 - Val Brickates Kennedy
Friday’s biggest advancing & declining stocks 2:55 p.m. June 10, 2011 - Kate Gibson
Drug stocks follow broader market south 12:10 p.m. June 10, 2011 - Val Brickates Kennedy
Chelsea Therapeutics soars on price target upgrade 9:01 a.m. June 10, 2011 - Val Brickates Kennedy
Monday’s biggest advancing and declining stocks 12:27 p.m. April 18, 2011 - MarketWatch
Wednesday’s biggest gaining and declining stocks 6:05 p.m. Feb. 2, 2011 - Kate Gibson

Does Accuray's Recent Unusual Bullish Options Activity Signal A Rally In The Stock Soon? 7:50 a.m. Jan. 28, 2014 - Seeking Alpha
Telecom Industry Stock Outlook - Jan 2014 - Zacks Analyst Interviews 5:37 a.m. Jan. 21, 2014 - Zacks.com
Telecom Industry Stock Outlook - Jan 2014 - Industry Outlook 5:37 a.m. Jan. 21, 2014 - Zacks.com
J.P. Morgan Confab Focus Reminds Us Upside Remains In Biotech 3:30 p.m. Jan. 17, 2014 - TheStreet.com
A Few Minutes With Chelsea's CEO on Tuesday's Northera Panel and Future Plans 10:33 a.m. Jan. 17, 2014 - TheStreet.com
Stocks You Wish You Owned on January 15 10:42 p.m. Jan. 16, 2014 - WallStreetSectorSelector
Chelsea Therapeutics May Be A Revenue Generating Biotech By The End Of 2014 3:02 p.m. Jan. 16, 2014 - Seeking Alpha
Company news for January 16, 2014 - Corporate Summary 10:06 a.m. Jan. 16, 2014 - Zacks.com
Chelsea Therapeutics International (CHTP) Soars: Stock Up 91.7% - Tale of the Tape 9:39 a.m. Jan. 16, 2014 - Zacks.com
FDA Panel Backs CHTP's Northera - Analyst Blog 6:10 p.m. Jan. 15, 2014 - Zacks.com
Can Chelsea Live Up to Its Potential This Time? 11:20 a.m. Jan. 15, 2014 - 247WallSt.com
2 Biotech Stocks in Play: Celsion and Chelsea 11:14 a.m. Jan. 15, 2014 - Wall St. Cheat Sheet
Sell-side weighs in as Chelsea Therapeutics soars 9:40 a.m. Jan. 15, 2014 - Seeking Alpha
Biotech Stock Roundup: Intercept Pharma Grabs the Limelight - Analyst Blog 9:31 a.m. Jan. 15, 2014 - Zacks.com
Morning Market Movers 8:54 a.m. Jan. 15, 2014 - benzinga.com
Top Analyst Upgrades and Downgrades: Intel, ExOne, GameStop, SodaStream and More 8:00 a.m. Jan. 15, 2014 - 247WallSt.com
Chelsea Therapeutics' Northera Gets Strong Support From FDA Panel 7:58 a.m. Jan. 15, 2014 - WSJ.com
Chelsea Therapeutics soars on outlook for Northera 7:50 a.m. Jan. 15, 2014 - Seeking Alpha
CHTP Stock – Chelsea Therapeutics Passes FDA Test, Stock Skyrockets 5:19 a.m. Jan. 15, 2014 - InvestorPlace.com
5 Biotech Stocks With Big Catalysts on the Horizon 3:26 a.m. Jan. 15, 2014 - InvestorPlace.com

Real Good Solar Takes On New Name, Ticker Symbol and Strategy: Real Goods Solar Inc. (NASDAQ:RSOL), Atossa Genetics Inc. (NASDAQ: ATOS), Chelsea Therapeutics International, Ltd. (NASDAQ:CHTP) 8:02 a.m. Jan. 28, 2014 - ACCESSWIRE
Chelsea Therapeutics Announces Joseph G. Oliveto Named President and Chief Executive Officer, Director 7:00 a.m. Jan. 27, 2014 - GlobeNewswire
Early 2014 Advancing Companies with Expansion & New Distribution Opportunities: RiceBran, Whole Foods, Hain Celestial, DryShips and Chelsea Therapeutics 9:05 a.m. Jan. 16, 2014 - PR Newswire - PRF
Opening Buzzers: Chelsea Therapeutics International, Tesla Motors Inc, NQ Mobile Inc, Rexahn Pharmaceuticals 11:02 a.m. Jan. 15, 2014 - ACCESSWIRE
FDA Advisory Panel Recommends Approval of Chelsea Therapeutics' NORTHERA(TM) (Droxidopa) for the Treatment of Symptomatic nOH 5:09 p.m. Jan. 14, 2014 - GlobeNewswire
Healthcare Companies Report Petition Submission, Pricing of Follow-On Offerings and Stock Price Movements - Research Report on Johnson & Johnson, GW Pharma, Conatus Pharma, Chelsea, and Insmed 8:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
Clinical Findings Presentations, Stock Price Movements, and Addition to Indexes - Research Report on Acceleron, AcelRx, Antares, Chelsea Therapeutics, and Clovis 8:00 a.m. Jan. 6, 2014 - PR Newswire
Announcements, Studies, and Corporate Updates by Healthcare Companies - Research Report on Horizon Pharma, Novavax, WuXi PharmaTech, Chelsea Therapeutics, and Anika Therapeutics 8:00 a.m. Dec. 24, 2013 - PR Newswire
Health Care Sector Insights: ZIOPHARM Oncology, Chelsea Therapeutics Intl., Antares Pharma, and Accuray 8:34 a.m. Dec. 19, 2013 - PR Newswire
Chelsea Therapeutics Announces First Patient Dosed in NORTHERA(TM) (droxidopa) Study 401 for the Treatment of Symptomatic nOH 7:00 a.m. Dec. 9, 2013 - GlobeNewswire
Today's Research: ZIOPHARM Oncology Inc., Antares Pharma Inc., Chelsea Therapeutics Intl. Ltd, and Accuray Inc. 1:29 p.m. Nov. 22, 2013 - PR Newswire
Study Results, Private Placements, Collaborations, Product Launches, and Public Offerings - Research Report on ViroPharma, Incyte, Tenet Healthcare, Sagent Pharmaceuticals and Chelsea Therapeutics 8:00 a.m. Nov. 22, 2013 - PR Newswire
Chelsea Therapeutics Completes Public Offering of Common Stock 10:32 a.m. Nov. 18, 2013 - GlobeNewswire
BBEP, CHTP, XGTI and SNTA added to NASDAQ Active Stock Watch List at GSR 10:33 a.m. Nov. 13, 2013 - ACCESSWIRE
Chelsea Therapeutics Announces Pricing of Public Offering of Common Stock 8:45 a.m. Nov. 13, 2013 - GlobeNewswire
Chelsea Therapeutics Announces Public Offering of Common Stock 5:50 p.m. Nov. 12, 2013 - GlobeNewswire
Chelsea Therapeutics Reports Third Quarter 2013 Financial Results 4:23 p.m. Nov. 5, 2013 - GlobeNewswire
Morning Research: Antares Pharma Inc., Chelsea Therapeutics Intl. Ltd, Accuray Inc., and ZIOPHARM Oncology Inc. 8:11 a.m. Oct. 30, 2013 - PR Newswire
Chelsea Therapeutics Announces FDA Advisory Committee to Review NORTHERA(TM) (droxidopa) 3:01 p.m. Oct. 9, 2013 - GlobeNewswire
Early Briefing and Review: Accuray Inc., Chelsea Therapeutics Intl. Ltd, ZIOPHARM Oncology Inc., and Antares Pharma Inc. 8:40 a.m. Oct. 8, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Memoir 'Pinball' Explores Life's Unpredictable Momentum

Funny how some folks think life has a road map. Let me tell you, it's more like a pinball machine, barely controllable and ready to surprise you with a tilt at any moment. And that's the essence of Marshall Barber's new memoir, 'PINBALL: Remembrances of a Flaneur.' Life's Roulette: Choices and Chance Barber takes readers on a raw ride through the byways of a life...

YR Fitness Rolls Out Innovator's Iron at FIBO 2027

A New Era of Strength Training Equipment? That's the question I asked myself when I heard about YR Fitness showcasing their latest gym gear at FIBO 2027. This isn't just another batch of machines rolling off the production line. YR Fitness has become quite the icon in China for strength equipment, and they're dead set on shaking up the market in Cologne, Germany from...

PG&E, Edison Push Liability Cap Amid Firestorm

The Thanksgiving Playbook Nobody Wanted Sacramento's corridors are buzzing with electric tension. And why? It's not some trivial turkey drama but a simmering scandal over two utility giants trying to sneak a liability cap into law faster than you can ask for a second slice of pumpkin pie. PG&E and Edison have a little secret—a covert strategy to limit shareholder...

Oracle's $20 Billion Offering: What Investors Need to Know

Oracle's Big Play: A $20 Billion Offering Nobody said playing in the big leagues was easy, and Oracle seems to be doubling down on that idea. Today, they spilled the beans on their ambition to rake in a cool $20 billion through an offering of common stock and senior notes. For those of us who keep a close eye on NYSE:ORCL, this is more than just a number—it's a signal...

Alfa Laval's Market Outlook: Strategic Plans Ahead

Alfa Laval's Vision for the Future Alfa Laval is gearing up for a dynamic Capital Markets Day on November 18, 2026. The Swedish engineering giant, renowned for heat transfer, separation, and fluid handling solutions, is setting the stage to outline bold strategies and ambitious targets. Investors should pay attention, as the company's roadmap charts a course towards a SEK...

ALS Research Gains Momentum as ACT for ALS Law Signed

A Major Stride in ALS Advocacy Today's not your usual day at the office for the folks championing the fight against ALS. With the President putting pen to paper, the ACT for ALS Act just turned into law, sending ripples through the community. Let me tell ya, legislation like this doesn't float by on a cloud—it's the result of grit, sleepless nights, and a dash of...

WareSpace Expands in U.S. with Key Site Acquisitions

WareSpace's National Growth Strategy: A New Expansion Chapter They say everything's bigger in Texas, but WareSpace is showing that smaller can be mighty impactful too. With its shrewd acquisition of sites in Houston's Inner Loop and Fremont's Warm Springs corridor, WareSpace is playing it smart, appeasing that roaring demand for tiny but mighty warehouse spaces across...

LITE, RRC, SGRY: Are Shareholders Getting Shortchanged?

What's Really Going On Here? Here's the skinny: Halper Sadeh LLC, that hard-hitting investor rights law firm, is poking their noses into some potential red flags over at a few companies you might have heard of—Lumentum Holdings (NASDAQ:LITE), Range Resources (NYSE:RRC), and Surgery Partners (NASDAQ:SGRY). They're sniffing around transactions that might leave the regular...

Kia's Thunderous October Sales Surge: What's Under the Hood?

Electric Pulse: Kia's Electrified Dreams Soar No one said the road to the top is easy, yet Kia America is cruising along with six straight months of shattering sales records. October's monumental figures paint the picture clear as a bell — 80,008 units dispatched to eager drivers, with electrified and hybrid models zooming to new heights. It ain't just the same old...

TEKLYNX 2026: Revolutionizing Barcode Labeling Tech

In the ever-evolving world of supply chain technology, a big move by TEKLYNX is making waves. The 2026 version of their barcode labeling software isn't just an upgrade—it's a full-blown transformation. They've fine-tuned their suite to align with the latest industry standards and integrated fresh capabilities that scream future-proofing. TEKLYNX's Game-Changing Upgrades...